Serum tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4, carbohydrate antigen 24-2, ferritin) and gastric cancer prognosis correlation

Table 1 General information of patients

Group	Age	CEA	CA19-9	CA24-2	CA72-4	Fer
Male (n = 143)	63.71 ± 9.07	31.00 ± 118.37	184.37 ± 716.08	139.68 ± 541.49	76.97 ± 762.42	259.39 ± 369.56
Female (n = 57)	57.35 ± 12.19	26.51 ± 106.57	167.06 ± 761.65	207.97 ± 1093.29	8.72 ± 24.59	209.23 ± 352.88
F/t	4.04	0.25	0.15	-0.59	0.67	0.88
P value	< 0.01	0.80	0.88	0.56	0.50	0.38

CEA: Carcinoembryonic antigen; CA: Carbohydrate antigen; Fer: Ferritin.

Table 2 Relationship between indicators and staging

Group		CEA	CA199	CA24-2	CA72-4	Fer	F	P value
Phase 1	Mean value	58.17	1.49	16.74	8.31	2.66	2.14	0.10
	Number of cases	30	30	30	30	30
	Standard deviation	12.21	0.37	22.50	22.73	3.90
Phase 2	Mean value	61.00	2.55	61.07	139.01	6.09	27.00	0.00
	Number of cases	51	51	51	51	51
	Standard deviation	11.26	0.32	251.26	740.53	10.94
Phase 3	Mean value	63.00	8.00	234.47	174.40	10.13	1.95	0.12
	Number of cases	92	92	92	92	92
	Standard deviation	9.48	6.28	965.73	886.66	25.40
Phase 4	Mean value	63.96	186.44	396.25	312.73	377.09	0.83	0.48
	Number of cases	27	27	27	27	27
	Standard deviation	9.02	267.09	739.39	569.28	1748.74

CEA: Carcinoembryonic antigen; CA: Carbohydrate antigen; Fer: Ferritin.

Table 3 Multi-factor analysis

Group	B	SE	P value	OR	95%CI
					Low limit	Upper limit
Gender	0.38	0.27	0.17	1.46	0.85	2.50
Age	0.02	0.01	0.15	1.02	0.99	1.04
CEA	0.00	0.00	0.15	1.00	1.00	1.00
CA199	0.00	0.00	0.98	1.00	1.00	1.00
CA24-2	0.00	0.00	0.56	1.00	1.00	1.00
CA72-4	0.00	0.00	0.00	1.00	1.00	1.00
Fer	0.00	0.00	0.16	1.00	1.00	1.00

CEA: Carcinoembryonic antigen; CA: Carbohydrate antigen; Fer: Ferritin; CI: Confidence interval; OR: Odds ratio.